Wall Street Experts
ver. ZuMIgo(08/25)
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Rachunek Zysków i Strat
Przychody TTM (mln): 4 253
EBIT TTM (mln): 805
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
Rok finansowy |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
227 |
270 |
302 |
348 |
302 |
429 |
565 |
510 |
531 |
631 |
710 |
858 |
974 |
1,235 |
1,416 |
1,875 |
2,219 |
2,944 |
3,647 |
3,258 |
3,336 |
3,780 |
3,952 |
4,159 |
Przychód Δ r/r |
0.0% |
18.9% |
11.7% |
15.5% |
-13.3% |
42.1% |
31.8% |
-9.7% |
4.1% |
18.7% |
12.5% |
20.8% |
13.6% |
26.8% |
14.6% |
32.5% |
18.3% |
32.7% |
23.9% |
-10.7% |
2.4% |
13.3% |
4.6% |
5.2% |
Marża brutto |
18.1% |
22.6% |
26.8% |
24.9% |
32.2% |
27.5% |
22.3% |
29.2% |
30.9% |
29.9% |
26.4% |
34.7% |
41.0% |
46.6% |
50.6% |
53.9% |
58.9% |
64.9% |
65.1% |
60.9% |
55.9% |
53.3% |
48.2% |
50.0% |
EBIT (mln) |
15 |
26 |
32 |
32 |
31 |
16 |
-10 |
-20 |
4 |
10 |
30 |
36 |
63 |
124 |
186 |
236 |
119 |
416 |
602 |
765 |
693 |
757 |
579 |
844 |
EBIT Δ r/r |
0.0% |
72.9% |
25.0% |
1.0% |
-4.5% |
-48.8% |
-163.1% |
104.1% |
-119.1% |
155.8% |
199.8% |
22.1% |
73.3% |
97.5% |
49.6% |
27.0% |
-49.7% |
250.6% |
44.6% |
27.1% |
-9.5% |
9.2% |
-23.5% |
45.7% |
EBIT (%) |
6.5% |
9.5% |
10.6% |
9.3% |
10.2% |
3.7% |
-1.8% |
-4.0% |
0.7% |
1.6% |
4.2% |
4.2% |
6.5% |
10.1% |
13.1% |
12.6% |
5.4% |
14.1% |
16.5% |
23.5% |
20.8% |
20.0% |
14.7% |
20.3% |
Koszty finansowe (mln) |
4 |
4 |
5 |
5 |
5 |
12 |
23 |
38 |
23 |
19 |
22 |
16 |
13 |
6 |
7 |
8 |
0 |
5 |
11 |
6 |
4 |
6 |
7 |
10 |
EBITDA (mln) |
19 |
32 |
43 |
48 |
43 |
53 |
55 |
69 |
69 |
73 |
98 |
100 |
134 |
187 |
267 |
358 |
620 |
521 |
731 |
881 |
864 |
939 |
801 |
1,147 |
EBITDA(%) |
8.5% |
11.8% |
14.2% |
13.9% |
14.4% |
12.3% |
9.8% |
13.6% |
12.9% |
11.5% |
13.7% |
11.7% |
13.7% |
15.1% |
18.8% |
19.1% |
27.9% |
17.7% |
20.0% |
27.0% |
25.9% |
24.9% |
20.3% |
27.6% |
Podatek (mln) |
5 |
6 |
7 |
9 |
6 |
7 |
1 |
8 |
4 |
1 |
8 |
8 |
11 |
20 |
30 |
39 |
84 |
44 |
81 |
106 |
80 |
82 |
85 |
125 |
Zysk Netto (mln) |
10 |
22 |
25 |
26 |
18 |
10 |
2 |
-18 |
4 |
13 |
29 |
32 |
64 |
107 |
165 |
212 |
264 |
370 |
520 |
653 |
613 |
662 |
619 |
712 |
Zysk netto Δ r/r |
0.0% |
123.4% |
14.0% |
1.5% |
-28.4% |
-43.2% |
-85.7% |
-1279.0% |
-121.2% |
243.6% |
125.8% |
8.8% |
103.1% |
66.4% |
54.3% |
28.3% |
24.7% |
40.0% |
40.6% |
25.5% |
-6.2% |
8.1% |
-6.5% |
15.0% |
Zysk netto (%) |
4.4% |
8.3% |
8.4% |
7.4% |
6.1% |
2.4% |
0.3% |
-3.5% |
0.7% |
2.0% |
4.1% |
3.7% |
6.6% |
8.7% |
11.7% |
11.3% |
11.9% |
12.6% |
14.3% |
20.0% |
18.4% |
17.5% |
15.7% |
17.1% |
EPS |
0.0502 |
0.0671 |
0.0766 |
0.0575 |
0.0568 |
0.0288 |
0.0031 |
-0.0365 |
0.0077 |
0.0265 |
0.0575 |
0.0521 |
0.11 |
0.17 |
0.24 |
0.26 |
0.33 |
0.43 |
0.64 |
0.83 |
0.75 |
0.77 |
0.72 |
0.83 |
EPS (rozwodnione) |
0.0502 |
0.0671 |
0.0766 |
0.0575 |
0.0568 |
0.0288 |
0.0031 |
-0.0365 |
0.0077 |
0.0265 |
0.0575 |
0.0521 |
0.11 |
0.17 |
0.24 |
0.26 |
0.33 |
0.43 |
0.64 |
0.83 |
0.75 |
0.77 |
0.72 |
0.83 |
Ilośc akcji (mln) |
905 |
905 |
905 |
481 |
481 |
488 |
481 |
486 |
487 |
487 |
506 |
608 |
605 |
647 |
687 |
766 |
805 |
867 |
814 |
791 |
817 |
860 |
861 |
858 |
Ważona ilośc akcji (mln) |
905 |
905 |
905 |
481 |
481 |
488 |
481 |
486 |
487 |
487 |
506 |
608 |
606 |
647 |
687 |
766 |
805 |
867 |
814 |
791 |
817 |
860 |
861 |
858 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |